Imeik Technology Development

Company

Last mentioned: Mar 21, 2026

Timeline

  1. Annual Results Announcement

    Official report confirms a retreat in full-year net income compared to the previous fiscal year.

  2. VBP Participation

    Company participates in multi-province centralized procurement for intraocular lenses, securing volume at lower price points.

  3. Aesthetics Expansion

    Haohai launches new line of high-end dermal fillers to compete in the premium aesthetics market.

Stories mentioning Imeik Technology Development 1

pharma Neutral

Haohai Biological Reports Full-Year Income Retreat Amid VBP Pressures

Shanghai Haohai Biological Technology Co., Ltd. has reported a decline in full-year income for the 2025 fiscal year, driven by margin compression in its core ophthalmology and orthopedic segments. The retreat highlights the ongoing challenges of China's volume-based procurement (VBP) policies and intensifying competition in the medical aesthetics market.

2 sources